Human cancer cell lines – overall cytotoxic activity

Human cancer cell lines – overall cytotoxic activity is a phenotypic classification used in pharmacological databases like ChEMBL to describe the broad anti-proliferative or lethal effects of compounds on various malignant cell populations (ChEMBL, 2024). It does not refer to a specific protein, enzyme, or receptor, but rather serves as a collective measure of a compound's ability to induce cell death or arrest the cell cycle (National Cancer Institute, 2023). This metric is frequently utilized in high-throughput screening (HTS) and the NCI-60 human tumor cell line screen to identify potential anticancer leads before their specific molecular targets are characterized (Shoemaker, 2006). Because this classification represents a functional outcome rather than a molecular entity, the drugs associated with it may act through diverse mechanisms such as DNA intercalation, tubulin polymerization inhibition, or disruption of metabolic pathways (PubChem, 2024). Consequently, while it is a critical parameter in oncology research, it is considered a descriptive assay endpoint rather than a therapeutic target in the traditional sense. This classification helps researchers identify compounds with potent bioactivity against cancer cells, though further mechanistic studies are required to determine the exact molecular interactions involved (NIH, 2024).

Other names

General cytotoxicityAnticancer phenotypic activityCell growth inhibitionIn vitro cytotoxic activityNCI-60 screening activity

Varies by compound; includes DNA intercalation, inhibition of mitosis, disruption of metabolic pathways, and induction of programmed cell death (PubChem, 2024).